신장이식 거부반응 시장 보고서(2026년)

Kidney transplant rejection is an immune-mediated condition in which the recipient's immune system identifies the transplanted kidney as foreign and mounts a response against it, resulting in impaired graft function or graft failure. It can occur as hyperacute, acute, or chronic rejection, each with distinct immunological mechanisms and clinical features. Management of kidney transplant rejection focuses on early detection, prevention, and treatment to preserve graft function and improve patient outcomes.

The principal types of kidney transplant rejection include chronic and acute rejection. Chronic rejection involves the gradual loss of kidney function over time due to immune-mediated damage to the transplanted organ. Treatments typically include immunosuppressive drugs and therapies targeting antibody-mediated rejection. Diagnostic approaches involve biomarker-based and genomics-based methods. Therapeutic options include small molecule inhibitors and biologic therapies, and the end users include transplant centers, hospitals, diagnostic laboratories, and pharmacies.

Tariffs are impacting the kidney transplant rejection market by increasing costs of imported diagnostic reagents, genomic testing kits, laboratory equipment, and specialized biologic therapeutics used in rejection detection and management. Transplant centers and diagnostic laboratories in North America and Europe are most affected due to reliance on cross-border supply chains for advanced testing technologies, while Asia-Pacific faces rising costs for imported immunological assays. These tariffs are contributing to higher diagnostic and treatment expenses and slowing adoption of advanced monitoring tools. However, they are also encouraging local manufacturing of diagnostic consumables, regional laboratory capability development, and increased investment in domestically produced transplant care solutions.

The kidney transplant rejection market research report is one of a series of new reports from The Business Research Company that provides kidney transplant rejection market statistics, including kidney transplant rejection industry global market size, regional shares, competitors with a kidney transplant rejection market share, detailed kidney transplant rejection market segments, market trends and opportunities, and any further data you may need to thrive in the kidney transplant rejection industry. This kidney transplant rejection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The kidney transplant rejection market size has grown strongly in recent years. It will grow from $3.51 billion in 2025 to $3.76 billion in 2026 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to increasing kidney transplant procedures, advancements in histopathological assessment techniques, wider availability of immunosuppressive drugs, growth of transplant center networks, improving post-transplant patient survival rates.

The kidney transplant rejection market size is expected to see strong growth in the next few years. It will grow to $5.01 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to rising demand for personalized immunosuppression strategies, increasing adoption of molecular diagnostics, expansion of precision medicine in transplant care, growing focus on long-term graft survival, increasing investment in transplant monitoring technologies. Major trends in the forecast period include increasing adoption of biomarker-based rejection monitoring, rising use of genomics-based diagnostic approaches, growing optimization of immunosuppressive therapy protocols, expansion of non-invasive rejection surveillance methods, enhanced focus on early detection of chronic rejection.

The increasing occurrence of end-stage renal disease is anticipated to drive the expansion of the kidney transplant rejection market in the coming years. End-stage renal disease (ESRD) denotes the ultimate, irreversible phase of chronic kidney disease in which the kidneys cannot perform adequately without dialysis or a kidney transplant. The prevalence of end-stage renal disease is growing due to the rising rates of chronic conditions, diabetes, and hypertension, which progressively impair kidney function and result in kidney failure. Kidney transplant rejection necessitates advanced monitoring and therapeutic strategies, directly aiding the management of end-stage renal disease by ensuring that transplanted kidneys continue to function and patients maintain kidney health. For example, in September 2024, according to the National Institute of Diabetes and Digestive and Kidney Diseases, a US-based government institute, more than 808,000 individuals in the United States were living with end-stage kidney disease (ESKD), also referred to as end-stage renal disease (ESRD), in 2023, with 68% receiving dialysis and 32% having undergone a kidney transplant. Consequently, the growing prevalence of end-stage renal disease is fueling the growth of the kidney transplant rejection market.

Leading companies operating in the kidney transplant rejection market are focusing on developing innovative diagnostic solutions, such as noninvasive urinary biomarker testing, to enable faster, safer, and more accurate detection of transplant rejection. Noninvasive urinary biomarker testing analyzes urine samples to detect molecular indicators of kidney inflammation or rejection, helping clinicians identify transplant complications quickly and safely without the need for invasive biopsies. For example, in May 2024, Thermo Fisher Scientific Inc., a US-based biotechnology company, launched the CXCL10 testing service, an innovative diagnostic tool for kidney transplant recipients. The CXCL10 test detects the CXCL10 chemokine in urine, which is associated with early transplant rejection and inflammation. It delivers results within 24 hours, enabling quicker clinical decisions, reducing the need for unnecessary biopsies, and improving patient convenience by utilizing noninvasive sample collection. Developed and validated by Thermo Fisher's One Lambda Laboratories, the assay combines high sensitivity and specificity with ease of use in clinical settings, supporting better post-transplant care and patient outcomes.

In July 2024, Biogen Inc., a US-based biotechnology company, acquired Human Immunology Biosciences for an undisclosed amount. With this acquisition, Biogen aimed to strengthen and expand its immunology and rare-disease pipeline by incorporating late-stage therapeutic assets and expertise in immune-mediated diseases. Human Immunology Biosciences is a US-based clinical-stage biotechnology company specializing in kidney transplant rejection.

Major companies operating in the kidney transplant rejection market are F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi SA, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Amgen Inc., Asahi Kasei Corporation, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Biogen Inc., ChugAI Pharmaceutical Co. Ltd., Eurofins Scientific SE, Illumina Inc., Natera Inc., CareDx Inc., Azurity Pharmaceuticals Inc., Insight Molecular Diagnostics, and RenalytixAI plc.

North America was the largest region in the kidney transplant rejection market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney transplant rejection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the kidney transplant rejection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The kidney transplant rejection market includes revenues earned by entities through transplant monitoring and diagnostic testing, immunological and histopathological assessments, clinical management of rejection episodes, immunosuppressive therapy administration and optimization, patient follow-up, and post-transplant care. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Kidney Transplant Rejection Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses kidney transplant rejection market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for kidney transplant rejection ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The kidney transplant rejection market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Rejection Type: Chronic Rejection; Acute Rejection
• 2) By Treatment: Immunosuppressive Drugs; Antibody-Mediated Rejection Therapies
• 3) By Diagnostic Approach: Biomarker-Based Diagnostics; Genomics-Based Diagnostics
• 4) By Therapeutics: Small Molecule Inhibitors; Biologic Therapies
• 5) By End-Users: Transplant Centers Or Hospitals; Diagnostic Laboratories; Pharmacies
• Subsegments:
• 1) By Chronic Rejection: Antibody Mediated Chronic Rejection; Chronic Allograft Nephropathy; Interstitial Fibrosis And Tubular Atrophy; Vascular Chronic Rejection; Mixed Chronic Rejection
• 2) By Acute Rejection: Cellular Acute Rejection; Antibody Mediated Acute Rejection; Hyperacute Rejection; Mixed Acute Rejection; Vascular Acute Rejection
• Companies Mentioned: F. Hoffmann-La Roche AG; Merck & Co. Inc.; Sanofi SA; Novartis AG; Bristol-Myers Squibb Company; Thermo Fisher Scientific Inc.; Takeda Pharmaceutical Company Limited; Amgen Inc.; Asahi Kasei Corporation; Teva Pharmaceutical Industries Ltd.; Astellas Pharma Inc.; Biogen Inc.; ChugAI Pharmaceutical Co. Ltd.; Eurofins Scientific SE; Illumina Inc.; Natera Inc.; CareDx Inc.; Azurity Pharmaceuticals Inc.; Insight Molecular Diagnostics; and RenalytixAI plc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Kidney Transplant Rejection Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Kidney Transplant Rejection Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Kidney Transplant Rejection Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Kidney Transplant Rejection Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Biomarker-Based Rejection Monitoring
  • 4.2.2 Rising Use Of Genomics-Based Diagnostic Approaches
  • 4.2.3 Growing Optimization Of Immunosuppressive Therapy Protocols
  • 4.2.4 Expansion Of Non-Invasive Rejection Surveillance Methods
  • 4.2.5 Enhanced Focus On Early Detection Of Chronic Rejection

5. Kidney Transplant Rejection Market Analysis Of End Use Industries

• 5.1 Transplant Centers Or Hospitals
• 5.2 Diagnostic Laboratories
• 5.3 Specialty Pharmacies
• 5.4 Clinical Research Organizations
• 5.5 Post-Transplant Care Clinics

6. Kidney Transplant Rejection Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Kidney Transplant Rejection Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Kidney Transplant Rejection PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Kidney Transplant Rejection Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Kidney Transplant Rejection Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Kidney Transplant Rejection Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Kidney Transplant Rejection Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Kidney Transplant Rejection Market Segmentation

• 9.1. Global Kidney Transplant Rejection Market, Segmentation By Rejection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Chronic Rejection, Acute Rejection
• 9.2. Global Kidney Transplant Rejection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Immunosuppressive Drugs, Antibody-Mediated Rejection Therapies
• 9.3. Global Kidney Transplant Rejection Market, Segmentation By Diagnostic Approach, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Biomarker-Based Diagnostics, Genomics-Based Diagnostics
• 9.4. Global Kidney Transplant Rejection Market, Segmentation By Therapeutics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Small Molecule Inhibitors, Biologic Therapies
• 9.5. Global Kidney Transplant Rejection Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Transplant Centers Or Hospitals, Diagnostic Laboratories, Pharmacies
• 9.6. Global Kidney Transplant Rejection Market, Sub-Segmentation Of Chronic Rejection, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Antibody Mediated Chronic Rejection, Chronic Allograft Nephropathy, Interstitial Fibrosis And Tubular Atrophy, Vascular Chronic Rejection, Mixed Chronic Rejection
• 9.7. Global Kidney Transplant Rejection Market, Sub-Segmentation Of Acute Rejection, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cellular Acute Rejection, Antibody Mediated Acute Rejection, Hyperacute Rejection, Mixed Acute Rejection, Vascular Acute Rejection

10. Kidney Transplant Rejection Market Regional And Country Analysis

• 10.1. Global Kidney Transplant Rejection Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Kidney Transplant Rejection Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Kidney Transplant Rejection Market

• 11.1. Asia-Pacific Kidney Transplant Rejection Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Kidney Transplant Rejection Market, Segmentation By Rejection Type, Segmentation By Treatment, Segmentation By Diagnostic Approach, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Kidney Transplant Rejection Market

• 12.1. China Kidney Transplant Rejection Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Kidney Transplant Rejection Market, Segmentation By Rejection Type, Segmentation By Treatment, Segmentation By Diagnostic Approach, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Kidney Transplant Rejection Market

• 13.1. India Kidney Transplant Rejection Market, Segmentation By Rejection Type, Segmentation By Treatment, Segmentation By Diagnostic Approach, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Kidney Transplant Rejection Market

• 14.1. Japan Kidney Transplant Rejection Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Kidney Transplant Rejection Market, Segmentation By Rejection Type, Segmentation By Treatment, Segmentation By Diagnostic Approach, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Kidney Transplant Rejection Market

• 15.1. Australia Kidney Transplant Rejection Market, Segmentation By Rejection Type, Segmentation By Treatment, Segmentation By Diagnostic Approach, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Kidney Transplant Rejection Market

• 16.1. Indonesia Kidney Transplant Rejection Market, Segmentation By Rejection Type, Segmentation By Treatment, Segmentation By Diagnostic Approach, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Kidney Transplant Rejection Market

• 17.1. South Korea Kidney Transplant Rejection Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Kidney Transplant Rejection Market, Segmentation By Rejection Type, Segmentation By Treatment, Segmentation By Diagnostic Approach, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Kidney Transplant Rejection Market

• 18.1. Taiwan Kidney Transplant Rejection Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Kidney Transplant Rejection Market, Segmentation By Rejection Type, Segmentation By Treatment, Segmentation By Diagnostic Approach, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Kidney Transplant Rejection Market

• 19.1. South East Asia Kidney Transplant Rejection Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Kidney Transplant Rejection Market, Segmentation By Rejection Type, Segmentation By Treatment, Segmentation By Diagnostic Approach, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Kidney Transplant Rejection Market

• 20.1. Western Europe Kidney Transplant Rejection Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Kidney Transplant Rejection Market, Segmentation By Rejection Type, Segmentation By Treatment, Segmentation By Diagnostic Approach, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Kidney Transplant Rejection Market

• 21.1. UK Kidney Transplant Rejection Market, Segmentation By Rejection Type, Segmentation By Treatment, Segmentation By Diagnostic Approach, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Kidney Transplant Rejection Market

• 22.1. Germany Kidney Transplant Rejection Market, Segmentation By Rejection Type, Segmentation By Treatment, Segmentation By Diagnostic Approach, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Kidney Transplant Rejection Market

• 23.1. France Kidney Transplant Rejection Market, Segmentation By Rejection Type, Segmentation By Treatment, Segmentation By Diagnostic Approach, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Kidney Transplant Rejection Market

• 24.1. Italy Kidney Transplant Rejection Market, Segmentation By Rejection Type, Segmentation By Treatment, Segmentation By Diagnostic Approach, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Kidney Transplant Rejection Market

• 25.1. Spain Kidney Transplant Rejection Market, Segmentation By Rejection Type, Segmentation By Treatment, Segmentation By Diagnostic Approach, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Kidney Transplant Rejection Market

• 26.1. Eastern Europe Kidney Transplant Rejection Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Kidney Transplant Rejection Market, Segmentation By Rejection Type, Segmentation By Treatment, Segmentation By Diagnostic Approach, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Kidney Transplant Rejection Market

• 27.1. Russia Kidney Transplant Rejection Market, Segmentation By Rejection Type, Segmentation By Treatment, Segmentation By Diagnostic Approach, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Kidney Transplant Rejection Market

• 28.1. North America Kidney Transplant Rejection Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Kidney Transplant Rejection Market, Segmentation By Rejection Type, Segmentation By Treatment, Segmentation By Diagnostic Approach, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Kidney Transplant Rejection Market

• 29.1. USA Kidney Transplant Rejection Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Kidney Transplant Rejection Market, Segmentation By Rejection Type, Segmentation By Treatment, Segmentation By Diagnostic Approach, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Kidney Transplant Rejection Market

• 30.1. Canada Kidney Transplant Rejection Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Kidney Transplant Rejection Market, Segmentation By Rejection Type, Segmentation By Treatment, Segmentation By Diagnostic Approach, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Kidney Transplant Rejection Market

• 31.1. South America Kidney Transplant Rejection Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Kidney Transplant Rejection Market, Segmentation By Rejection Type, Segmentation By Treatment, Segmentation By Diagnostic Approach, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Kidney Transplant Rejection Market

• 32.1. Brazil Kidney Transplant Rejection Market, Segmentation By Rejection Type, Segmentation By Treatment, Segmentation By Diagnostic Approach, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Kidney Transplant Rejection Market

• 33.1. Middle East Kidney Transplant Rejection Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Kidney Transplant Rejection Market, Segmentation By Rejection Type, Segmentation By Treatment, Segmentation By Diagnostic Approach, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Kidney Transplant Rejection Market

• 34.1. Africa Kidney Transplant Rejection Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Kidney Transplant Rejection Market, Segmentation By Rejection Type, Segmentation By Treatment, Segmentation By Diagnostic Approach, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Kidney Transplant Rejection Market Regulatory and Investment Landscape

36. Kidney Transplant Rejection Market Competitive Landscape And Company Profiles

• 36.1. Kidney Transplant Rejection Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Kidney Transplant Rejection Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Kidney Transplant Rejection Market Company Profiles
  • 36.3.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

37. Kidney Transplant Rejection Market Other Major And Innovative Companies

• Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Amgen Inc., Asahi Kasei Corporation, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Biogen Inc., Chugai Pharmaceutical Co. Ltd., Eurofins Scientific SE, Illumina Inc., Natera Inc., CareDx Inc., Azurity Pharmaceuticals Inc., Insight Molecular Diagnostics, RenalytixAI plc

38. Global Kidney Transplant Rejection Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Kidney Transplant Rejection Market

41. Kidney Transplant Rejection Market High Potential Countries, Segments and Strategies

• 41.1 Kidney Transplant Rejection Market In 2030 - Countries Offering Most New Opportunities
• 41.2 Kidney Transplant Rejection Market In 2030 - Segments Offering Most New Opportunities
• 41.3 Kidney Transplant Rejection Market In 2030 - Growth Strategies
  • 41.3.1 Market Trend Based Strategies
  • 41.3.2 Competitor Strategies

42. Appendix

• 42.1. Abbreviations
• 42.2. Currencies
• 42.3. Historic And Forecast Inflation Rates
• 42.4. Research Inquiries
• 42.5. The Business Research Company
• 42.6. Copyright And Disclaimer